215 related articles for article (PubMed ID: 19609716)
1. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
3. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.
Kalkanci A; Sugita T; Arikan S; Yucesoy M; Ener B; Otag F; Kiraz N; Kustimur S; Sancak B; Evci C; Emektas G
Med Mycol; 2010 Feb; 48(1):141-6. PubMed ID: 19462333
[TBL] [Abstract][Full Text] [Related]
5. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
6. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1.
Rodriguez-Tudela JL; Gomez-Lopez A; Alastruey-Izquierdo A; Mellado E; Bernal-Martinez L; Cuenca-Estrella M
Diagn Microbiol Infect Dis; 2007 Aug; 58(4):435-40. PubMed ID: 17509802
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
8. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
Tsuji Y; Tokimatsu I; Sugita T; Nozaki M; Kobayashi D; Imai K; Kogawa K; Nonoyama S
Pediatr Infect Dis J; 2008 Nov; 27(11):1035-7. PubMed ID: 18845986
[TBL] [Abstract][Full Text] [Related]
10. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility patterns and molecular identification of Trichosporon species.
Rodriguez-Tudela JL; Diaz-Guerra TM; Mellado E; Cano V; Tapia C; Perkins A; Gomez-Lopez A; Rodero L; Cuenca-Estrella M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4026-34. PubMed ID: 16189076
[TBL] [Abstract][Full Text] [Related]
12. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM
Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Falk R; Wolf DG; Shapiro M; Polacheck I
J Clin Microbiol; 2003 Feb; 41(2):911. PubMed ID: 12574315
[No Abstract] [Full Text] [Related]
14. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.
Guo LN; Xiao M; Kong F; Chen SC; Wang H; Sorrell TC; Jiang W; Dou HT; Li RY; Xu YC
J Clin Microbiol; 2011 Nov; 49(11):3805-11. PubMed ID: 21900517
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
[TBL] [Abstract][Full Text] [Related]
16. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
17. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.
Taj-Aldeen SJ; Al-Ansari N; El Shafei S; Meis JF; Curfs-Breuker I; Theelen B; Boekhout T
J Clin Microbiol; 2009 Jun; 47(6):1791-9. PubMed ID: 19321719
[TBL] [Abstract][Full Text] [Related]
19. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan.
Yang YL; Liu YW; Chen HT; Tsai MS; Chu WL; Lo HJ
Med Mycol; 2013 Nov; 51(8):880-3. PubMed ID: 23768241
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis.
Sugita T; Ikeda R; Nishikawa A
J Clin Microbiol; 2004 Dec; 42(12):5467-71. PubMed ID: 15583267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
